Editas Get A Vetr Upgrade To Strong Buy

By: via Benzinga
The Vetr crowd Monday upgraded their rating for Editas Medicine Inc (NASDAQ: EDIT), from 4 stars (Buy), issued 313 days ago, to 5 stars ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.